Key result
Cardiac-specific overexpression of Rgs5 protected mice against pressure overload-induced cardiac hypertrophy and fibrosis by inhibiting MEK-ERK1/2 signaling.
Why the study?
Does cardiac-specific overexpression of human Rgs5 gene prevent cardiac hypertrophy and fibrosis in mice subjected to pressure overload?
Population
Transgenic mice with cardiac-specific overexpression of human Rgs5 gene and Rgs5-/- mice subjected to…
Comparison
Cardiac-specific overexpression of human Rgs5 gene vs Rgs5-/- mice (knockout model)
Design
Preclinical
Authors
Loading...
Hypothesis-generating for Rgs5 as anti-remodeling target; leaves open translation to human pressure-overload heart failure.
Does cardiac-specific overexpression of human Rgs5 gene prevent cardiac hypertrophy and fibrosis in mice subjected to pressure overload?
Rgs5 protects against pathological cardiac remodeling and fibrosis during pressure overload by inhibiting MEK-ERK1/2 signaling, highlighting its potential as a therapeutic target in heart failure.
Li et al. (2010) studied Cardiac hypertrophy and fibrosis. Cardiac-specific overexpression of human Rgs5 vs. Wild-type littermates was evaluated on Cardiac hypertrophy and fibrosis. Cardiac-specific overexpression of Rgs5 protected mice against pressure overload-induced cardiac hypertrophy and fibrosis by inhibiting MEK-ERK1/2 signaling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: